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Abstract Connexins form a family of transmembrane proteins that consists of 20members in humans and 21members inmice. Six
connexins assemble into a connexon that can function as a hemichannel or connexon that can dock to a connexon
expressed by a neighbouring cell, thereby forming a gap junction channel. Such intercellular channels synchronize
responses in multicellular organisms through direct exchange of ions, small metabolites, and other second messenger
molecules between the cytoplasms of adjacent cells. Multiple connexins are expressed in the cardiovascular system.
These connexins not only experience the different biomechanical forces within this system, but may also act as effector
proteins in co-ordinating responses within groups of cells towards these forces. This review discusses recent insights
regarding regulation of cardiovascular connexins by mechanical forces and junctions. It specifically addresses effects of
(i) shear stress on endothelial connexins, (ii) hypertension on vascular connexins, and (iii) changes in afterload and the
composition of myocardial mechanical junctions on cardiac connexins.
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1. Connexins in the cardiovascular
system
Connexins form a family of transmembrane proteins that consists of 20
members in humans and 21 members in mice. Oligomerization of six
connexins results in the formation of a connexon. Such a connexon
can dock to a connexon expressed by a neighbouring cell, thereby
forming a gap junction channel.1 These channels are crucial for gap junc-
tional intercellular communication (GJIC) as they allow passage of small
molecules from the cytosol of one cell to another. Classically, ions and
metabolites ,1000 Da, e.g. ATP, Ca2+, cAMP, and IP3, are known to
pass through gap junction channels. But larger molecules, such as pep-
tides and small nucleotides, have also been shown to be able to diffuse
through gap junctions.2–4 In addition, a connexon can also function as
a hemichannel and allow diffusion of molecules between the cytoplasm
and the extracellular space.5
The most abundantly expressed connexins in the cardiovascular
system are connexin37 (Cx37), Cx40, Cx43, and Cx45. The expression
of these proteins displays a large heterogeneity throughout the circula-
tory system (i.e. arteries, veins, lymphatic vessels, and the heart). In the
vessels of healthy subjects, endothelial cells (ECs) of large conduit arter-
ies expressCx37 andCx40,whereasCx43and (to amuch lowerextent)
Cx45 aremostly expressedby vascular smoothmuscle cells (VSMCs).6,7
The level andpatternof connexin expression in conduit arteries changes
with age and during atherogenesis,6,8 suggesting that connexins may be
contributing to the latter process. In the apolipoprotein-E-deficient
(ApoE2/2) mouse model for atherosclerosis, it has indeed been
shown that Cx37 and Cx40 display atheroprotective properties,9,10
whereas Cx43 appeared pro-atherogenic.11 Recently, both Cx37 and
Cx40 have been described to interact with endothelial nitric oxide syn-
thase (eNOS) in aortic ECs.12,13 This suggests that both Cx37 andCx40
may regulate release of eNOS-derived nitric oxide (NO). In agreement
with these findings, it has been shown that Cx40-deficient (Cx402/2)
mice, which are also characterized by a reduced endothelial Cx37 ex-
pression, display diminished agonist-induced endothelium-dependent
vasodilatation.12 In addition, in vitro evidence suggests that Cx37 inhibits
eNOS-dependent NO production.13 However, arteries from Cx37-
deficient mice (Cx372/2) exhibit proper endothelium-dependent
relaxation ex vivo.14 Compared with conduit arteries that fully depend
on NO for endothelium-dependent relaxations, smaller blood vessels
typically depend largely on endothelium-derived hyperpolarization for
endothelium-mediated control of vascular tone.15 Interestingly, ECs
and VSMCs of small muscular resistance arteries express Cx37, Cx40,
and Cx43.16,17 In these arteries, connexins are involved in the spreading
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of endothelium-dependent vasodilatation and relaxation induced by
endothelium-derived hyperpolarizing factor(s).18,19 ECs of large veins
have been described to express Cx37, Cx40, and Cx43,20 although
Cx40 and Cx37 expression levels seem lower than those of the
aorta.21 Finally, lymphatic ECs express Cx37, Cx43, and Cx47,22,23
and recently Cx37 has been shown to be of crucial importance for the
formation of lymphatic valves;22,23 i.e. Cx372/2 mice lack lymphatic
valves and therefore display reduced lymph flow.22,23 More recently,
Cx37 has been reported to be critically involved in the formation of
venous valves as well.24
Classically, connexins expressed by the working myocardium con-
tribute to synchronization of cardiac contractions by electrically coup-
ling cardiomyocytes. However, cardiac connexins can also play a
deleterious role, e.g. after periods of ischaemia by passing so-called
‘death signals’ from one cardiomyocyte to the next.25,26 Healthy ven-
tricular myocardium mainly expresses Cx43 and, to a lesser extent,
Cx45, and healthy atrial myocardium expresses high levels of both
Cx40 and Cx43 in addition to small amounts of Cx45.25 Cells that
form the electrical conduction system responsible for the rapid
spread of electrical signals from the sinoatrial node towards the ventri-
cles have been described to express a variety of connexins (i.e. Cx45,
Cx43, Cx40, and Cx30). The particular set of connexins expressed by
these cells is strongly dependent on their location.27 In summary, mul-
tiple connexins are expressed in the cardiovascular system that not
only experience the different biomechanical forces within this system,
but may also act as effector proteins in co-ordinating responses within
groups of cells towards these forces.
2. Effect of shear stress in arteries
It is increasingly recognized that the endothelium lining the cardiovascu-
lar system is highly sensitive to haemodynamic shear stresses, which act
at the vessel luminal surface in the direction of blood flow. Wall shear
stress, the frictional force between blood and the endothelium, is
more and more recognized as a key determinant of EC function, gene
expression, and structure.28 In this respect, Kru¨ppel-like factor 2
(KLF2) and nuclear factor-E2-related factor-2 (Nrf2) transcription
factors have been identified as central regulators of physiological
responses to arterial shear stress.29 In straight portions of arteries,
KLF2 is induced in ECs exposed to prolonged high laminar shear
stress (HLSS) where it regulates the expression of anti-inflammatory
and anti-coagulant proteins, such as eNOS and thrombomodulin.
HLSS also activates Nrf2, a transcription factor that regulates redox
levels by induction of numerous anti-oxidant enzymes such as heme
oxygenase-1. Physiological variations in shear stress regulate acute
changes in bloodvessel diameter and,when sustained, induce slowadap-
tive vascularwall remodelling.As aconsequence, atherosclerotic lesions
develop predominantly near side branches of arteries, i.e. where blood
flow is oscillatory, or at the lesser curvature of bends of the arterial tree,
i.e. where blood flow rates are relatively low.30 ECs in these areas of low
or oscillatory shear stress (OSS) display activation of nuclear factor kB
(NFkB) and activationprotein 1 transcription factors, resulting in the ex-
pression of pro-inflammatory genes such as vascular cell adhesion
molecule-1 (VCAM-1), E-selectin, and interleukin-8 (IL-8).31 In brief,
the arterial endothelium is continuously exposed to regional differences
in shear stress, which induces differential transcriptional activity in
adjacent territories.
3. Connexins as effector proteins in
co-ordinating shear stress responses?
Intercellular channels formed by connexins provide a simple method of
synchronizing responses in multicellular organisms through direct ex-
change of ions, small metabolites, and other second messenger mole-
cules between adjacent cells.32,33 This type of intercellular signalling is
implicated in rapid co-ordinated activities such as contraction of the
heart.34 In contrast, GJIC has to be restricted between adjacent territor-
ieswithdifferent functionoractivationstate.Gap junctions in the arterial
endothelium are known to consistmainly of Cx40 andCx37.7,35 Cx43 is
moderately expressed or absent in the quiescent arterial endothelium,
but is induced under conditions associatedwith endothelial dysfunction.
Gabriels andPaul36 observed thatCx43wasnotdetectable inmostparts
of the rat aorta but very abundant in small clusters of cells localized at the
downstream edge of ostia of branching vessels or flow dividers. More-
over, when they created flow disturbances in vivo by surgical coarctation
(by ligature) of the aorta leading to a 30% reduction in vessel diameter,
increased Cx43 expression was observed in areas of pronounced oscil-
latory flow, whereas Cx40 expression levels were unchanged by this
treatment. In contrast, Cx37 expression seemed down-regulated in
these regions and very little co-expression of Cx37 and Cx43 was
observed.Although aortic coarctationwill induce significant flowdistur-
bances, an effect of arterial compressiononconnexin expression cannot
be completely ruled out using this model. It is, therefore, interesting that
the relationbetween shear stress andconnexin expressionhas alsobeen
investigated on upstream and downstream surfaces of rat cardiac valves
that are naturally subjected to very different intensities of shear stress.37
The authors observed up to 200-fold greater expression of Cx43 in the
ECs on the upstream compared with the downstream surfaces. In con-
trast, Cx37 expression was equal in both endothelia and Cx40 was not
detected at all. Although ECs covering cardiac valves are also exposed to
highpressures, it remainsdifficult to compare thesecellswith the arterial
endothelium, given their different haemodynamic environment.
In addition to these early in vivo studies, several in vitro studies have
been performed to investigate the correlation between Cx43 expres-
sion and different biomechanical forces on various types of ECs. In a
first preliminary report,38 a four-fold increase in Cx43 mRNA levels in
porcine aortic ECs was reported already after 1 h of 15 dynes/cm2
LSS, which remained elevated for the complete investigated period
(24 h). This report was followed by a sophisticated and detailed
study39 in which the spatial and temporal regulation of Cx43 mRNA
and protein as well as intercellular communication was mapped in
monolayers of bovine aortic ECs exposed to controlled flowconditions.
At short term (5 h), endothelial Cx43was increased under conditions of
both laminar flow and in areas of flow separation and recirculation com-
pared with no-flow controls. However, after 16 and 30 h of shear
stress, Cx43 expression remained increased in cells subjected to dis-
turbed flow, but Cx43 expression returned to normal levels in regions
of undisturbed laminar flow. The differences in Cx43 expression were
matched by an increased level of intercellular spread of Lucifer
Yellow, a Cx43-permeable dye, in the region of disturbed flow. The
effects of pulsed unidirectional and OSS in combination with different
levels of hydrostatic pressure and circumferential stretch on Cx43 ex-
pression was investigated in PymT-transformed mouse ECs (bEnd.3),
expressing all the three endothelial connexins, that were grown to
confluence on the inside of elastic tubes.40 Interestingly, increased
Cx43 expression was observed after 24 h of modest levels of both
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pulsatile LSS and OSS, although the rise in Cx43 expression reached
higher levels (up to three-fold) under OSS. In addition, 4% (change of
diameter) circumferential stretch caused a significant increase in Cx43
protein levels after 4 h that remained elevated after 24 h. In contrast,
raising pressure from 100 to 150 mmHg for up to 24 h had no effect
on Cx43 expression in ECs. Altogether, these studies provide clear evi-
dence that endothelial Cx43 expression is sensitive to changes in the
haemodynamic environment, in particular to OSS. Although NFkB
andmitogen-activatedproteinkinasepathwaysare likely candidates,41,42
the mechanism by which OSS induces Cx43 expression in arterial ECs
still remains to be established.
As mentioned before, most ECs in the aorta express high levels of
Cx37, but this expression is lost in ECs at bifurcations and in ECs over-
lying atherosclerotic plaques.6An increasing numberof largemicroarray
data sets have become available in which gene expression patterns in
various shear stress regions have been compared with each other or
to static culture conditions. These microarrays have provided rather in-
consistent data regarding the regulation of endothelial Cx37 expression
by shear stress.43–46 As described above, HLSS is known to be vaso-
protective through the induction of KLF2. As the promoter region of
the Cx37 gene contains many KLF consensus binding sites, we hypothe-
sized that shear stress, throughmodulation of KLF2, may regulate Cx37
expression in the arterial endothelium. Using 16-week-old atherosus-
ceptibleApoE2/2mice,wefirst confirmed thatCx37 is highly expressed
in the straight region of the common carotid artery of these mice,
whereas it is reduced at the carotid bifurcation.47 The differences in
Cx37expressionwere accompaniedby a decreased level of intercellular
spread of propidium iodide, a Cx37-permeable dye, in the bifurcation
region. We then used shear stress-modifying vascular devices that
impose specific flow patterns in mouse carotid arteries.48 We found
that Cx37 expression was down-regulated in regions of altered flow
(either LLSS orOSS), but was conserved in regions of HLSS (Figure 1).47
To further study themechanisms involved, bEnd.3or humanumbilical
veinECs (HUVECs)wereexposed to shear stress in vitro. Cx37andKLF2
expression were increased after 24 h of HLSS (25 dynes/cm2). Interest-
ingly, Cx37 expressionwas reduced after silencing KLF2, suggesting that
KLF2 indeed acts as a transcription factor for this gap junction protein.
Moreover, binding of KLF2 to the promoter region ofCx37was demon-
strated by chromatin immunoprecipitation. We finally used a scrape-
loading dye transfer approach and determined that gap junctional
permeability to propidium iodide was severely impaired following
KLF2 silencing in a monolayer of ECs. Altogether, this study demon-
strated that shear stress, by modulating KLF2 expression, forms distinct
communication compartments in arteries, with atherosusceptible
regions expressing less Cx37 and displaying less intercellular diffusion
of the cationic dye propidium iodide than the protected regions.47
This compartmentalization could, for example, be beneficial by limiting
spread of specific pro-inflammatory mediators away from the region
subjected to disturbed flow. On the other hand, shear stress-induced
Cx37 may be involved in synchronizing endothelial responses to
protective circulating factors.
Cx37 is also expressed in lymphatic ECs. However, in contrast to the
arterial endothelium, its expression is mostly limited to regions of valve
formation that are exposed to (low)OSS.23 Interestingly, recent studies
demonstrated a severe impairment of lymphatic valve formation and
function in Cx372/2 mice.22,23 Based on in vitro studies in which lymph-
atic ECs were exposed to physiological values of OSS, the authors
proposed a mechanism for lymphatic valve formation in which Cx37
acts downstream of the lymphatic endothelial transcription factors
Prox1/Foxc2 and shear stress, leading to a synchronized calcineurin/
nuclear factor of activated T-cells (NFAT) activation in response to
flow.23 Mechanistically, Cx37 gap junctions may mediate transfer of
IP3, which triggers release of intracellular Ca
2+ necessary for calci-
neurin/NFAT activation. However, involvement of other second mes-
senger pathways cannot be excluded. Although the effector role of
Cx37 in forming communication compartments in the lymphatic or ar-
terial endothelium is similar, it remains very intriguing that the signalling
pathways inducing the expression of the effector protein are dependent
on a different, almost opposite, typeof shear stress that up-regulates dis-
tinct transcription factors. Of note, Cx372/2 mice also lack venous
valves.24 And although the mechanism of Cx37 expression in venous
valveshasnotbeen investigatedyet, onecan imagine that similarmolecu-
lar pathways control valve development in veins and lymphatic vessels,
since they share a common embryonic origin.
Cx40 expression in the endothelium of large arteries seems to have
little sensitivity to flow disturbances. Indeed, Cx40 expression is high in
the straight portion of the mouse carotid artery and seems unaltered at
the carotid bifurcation.47 Moreover, Cx40 expression levels in the
mouse aortic ECs were not affected by surgical coarctation.36 Similar
to KLF2, KLF4 transcription is induced in arteries by HLSS and this
transcription factor subsequently regulates the expression of (vaso-
protective) target genes. Interestingly, Cx40 mRNA expression in
cultured ECs was moderately down-regulated by KLF4 siRNA, while
it remained unaffected by KLF2 silencing.47 Whether arterial Cx40
expression is directly regulated by KLF4 or whether additional shear
stress-responsive transcription factors are involved remains to be
investigated.
More mechanistic details on the relation between shear stress and
Cx40 are available from studies in the microvasculature, where shear
stress causes a long-term induction of Cx40 protein expression. This
Cx40 expression is greatly reduced by inhibiting PI3 kinase or Akt,
with PI3K activity being required for basal Cx40 expression and Akt ac-
tivity taking part in shear stress-dependent induction of Cx40.49 As
endothelial Cx40 plays an important role in signal propagation along
the wall of arterioles,35,50 this induction of Cx40 expression may have
important functional consequences for the adaptation of microvascular
networks.
Arterial pressure fluctuates as a result of the rhythmic activity of the
heart. The effects of constant and pulsatile shear on the expression of
arterial identity genes have been investigated by using a combination
of approaches ranging from in vitro ECs cultures, the developing
chicken embryo yolk sac vasculature, and mouse occlusion models. Re-
cently, Buschmann et al.51 elegantly demonstrated that a combination of
pulsatile shear andCx40 is of critical importance for arterial identity and
remodelling events during flow-driven arteriogenesis.
Altogether, the presently available studies point to a strong function
for Cx40 in endothelial synchronization of mechanosensitive responses
in the microvasculature, whereas Cx43 and Cx37 seem crucial for
mechanosensitive compartmentalization in the arterial and lymphatic
endothelium.
4. Hypertension and connexins
Hypertension is a chronic disease that can be subdivided in systemic
hypertension and pulmonary hypertension. Systemic hypertension is
estimated to affect up to one-third of the Western population and
likely accounts for 16% of all deaths annually.52 The pathophysiology
underlying the majority of cases remains poorly understood and
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therefore this disease is defined clinically. Systemic hypertension is
defined as (i) a systolic blood pressure .140 mmHg or (ii) a diastolic
blood pressure .90 mmHg or (iii) normal blood pressure but on anti-
hypertensive therapy or (iv) being told at least twice by a health profes-
sional that one suffers from hypertension.52 Pulmonary hypertension
has been defined as a mean pulmonary arterial pressure .25 mmHg
at rest as assessed by right heart catheterization.53,54 Pulmonary hyper-
tension affects 10–20% of the general population and is more prevalent
in females compared with males.55–57
Connexins are widely expressed in organs involved in the pathogen-
esis of both systemic hypertension (e.g. ECs, VSMCs, and renin produ-
cing cells in the kidney) and pulmonary hypertension (e.g. pulmonary
artery ECs and pulmonary fibroblasts). In addition, connexins are
expressed in organs suffering from the consequences of both diseases
(e.g. the left ventricle, which experiences increased afterload during sys-
temic hypertension, and the right ventricle which is exposed to
increased afterload during pulmonary hypertension). Despite the fact
that many animal models have been used to study connexins in the
contest of systemic hypertension, there is surprisingly little consensus
regarding the effect of hypertension on connexin expression (for an
overview, see Table 1). In addition, the molecular mechanisms by
which hypertension affects connexins are largely unknown.
5. Connexins in renin- and
NO-dependent hypertension
Inmodels of renin-dependent hypertension [e.g. theDOCA-salt and the
2-kidney, 1-clipGoldblatt (2K1C)models], the expressionof bothCx40
andCx43 increases albeit in a vessel- and time-dependentmanner.41,58–
60 Although the expression of Cx40 increases in both kidneys in the
2K1C model, the expression of Cx43 only increases in the unclipped
kidney, suggesting that this increased Cx43 is a consequence of the
rise in intravascular pressure rather than a more general stimulus.61
Moreover, Cx43 but notCx40 increases in aortic VSMCs ofDOCA-salt
or 2K1C rats,61 whereas in mice these procedures induce an
up-regulation of both Cx43 and Cx37 in aortic VSMCs.41 It has, there-
fore, been suggested that Cx43 is particularly sensitive to the haemo-
dynamic changes that are associated with both models of
hypertension rather than being sensitive to renin that displays opposite
changes in these two animals models. This attractive suggestion has,
however, been undermined by the fact that Cx43 expression appeared
decreased in aortas fromrats suffering fromL-NAME-inducedhyperten-
sion.62,63 Thus, haemodynamic changes per se do not necessarily lead to
increased expression of Cx43 in aortic VSMCs. Importantly, decreased
Cx43 expression in L-NAME-induced hypertension was fully reversed
bya7-day treatmentwith thenon-selectivebeta-adrenergic blockercar-
vedilol, whereas treatment with the selective beta1-receptor antagonist
atenolol only partially reversed the effects of hypertension on Cx43
expression (although the reduction in blood pressure was similar
between the treatments), suggesting a blood pressure-independent
role for beta2-receptor agonism on Cx43 expression in VSMCs. Of
note, Cx40 expression was not altered by hypertension nor drug treat-
ment in any of the groups.63
6. Connexins in rat and mouse
models of genetic hypertension
In addition to studies focusing on changes in connexin expression in
models that depend on pharmacological (e.g. L-NAME-induced
hypertension) or surgical (e.g. the 2K1C model) interventions to
Figure 1 (A) High laminar shear stress is atheroprotective partly through induction of Kruppel-like factor 2 that, in turn, up-regulates Cx37 expression
and, therefore, ensures co-ordination of endothelial responses. Representative images of Cx37 (green) in the endothelium of carotid arteries exposed to
low laminar (B), high laminar (C) or oscillatory shear stress (D) in vivo. HLSS, high laminar shear stress; KLF2, Kruppel-like factor 2; LLSS, low laminar shear
stress; OSS, oscillatory shear stress; SSS, shear stress sensor.
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induce hypertension, connexin expression has also been studied in
spontaneously hypertensive rats (SHR). The endothelium lining caudal
arteries isolated from 3-week-old (i.e. the pre-hypertensive period)
SHR or Wistar Kyoto (WKY) control rats expresses similar amounts
of Cx37 and Cx43, whereas the expression of Cx40 is significantly
lower in SHR ECs.64 Moreover, the expression of Cx37, Cx40, and
Cx43was not affected by age in theWKY arteries. However, compared
with arteries isolated from 3-week-old pre-hypertensive SHR rats, the
expression of Cx37, Cx40, and Cx43 was significantly decreased in
the arterial endothelium of 12-week-old SHR.64 A more recent study
from the same group focused on the expression of connexins in the
aortic wall of pre-hypertensive and hypertensive SHR compared with
normotensive WKY.65 In this study, no differences were detected
between SHR and WKY aortas in the pre-hypertensive period.
However, aortas from hypertensive rats displayed reduced endothelial
Cx37 and Cx40 but increased expression of Cx37 and Cx43 in the
media.65 Mechanistically, treatment of SHR using an inhibitor of the
angiotensin-converting enzyme (ACE) normalized blood pressure and
connexin expression.65 However, since the study did not include a
control group in which blood pressure was lowered using an aspecific
vasorelaxant (e.g. hydralazine) it is unclearwhether this effect ofACE in-
hibition was a direct effect on connexin expression or an indirect effect
caused by a lower blood pressure. Indeed, an earlier study focusing on
the molecular mechanism that regulates the expression of connexins
inmesenteric arteries from SHR andWKY rats66 showed that endothe-
lial Cx37 and Cx40 expression was significantly lower, whereas Cx43
was significantly higher in SHR compared with WKY mesenteric arter-
ies. In this study, angiotensin receptor (AT) blockage reduced the
blood pressure of SHR, increased the expression of both Cx37 and
Cx40, and decreased the expression of Cx43. However, the
combination of hydralazine and hydrochlorothiazide lowered
thebloodpressure toa similarextent, but didnot correct theexpression
of eitherCx37orCx40,66 thus rulingout adirecteffect of loweredblood
pressure on connexin expression. Finally, connexin abundance has also
been studied in the renal resistance arteries of SHR andWKY rats.67 At
this location, Cx40 and Cx43 expression was similar for both strains of
rats. However, Cx37 was 2.4-fold decreased in SHR renal resistance ar-
teries. Renal resistance arteries from normotensive Sprague–Dawley
rats displayed equal Cx37 expression compared with SHR arteries sug-
gesting that the decreased Cx37 expression in the SHR arteries was not
due to the difference in blood pressure but was likely due to differences
between the strains of rats. Finally, the effect of hypertension on con-
nexin expression was studied in Cx402/2 mice.12,41,68,69 These mice
are hypertensive and are characterized by an increased expression of
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Table 1 Effect of hypertension on connexin expression in the cardiovascular system
Species Model Cx37 Cx40 Cx43 Cx45 Note Ref.
Rat SPSHR ND ND (mesenteric arterial cell
culture)
ND [112]
Rat DOCA-salt ND ND (aorta) ND [60]
Rat 2K1C ND ND (aorta),(cardiomyocyte) ND [58,59]
Rat DOCA-salt ND ND (aorta),(cardiomyocyte) ND [58,59]
Rat L-NAME ND ND (aorta),(cardiomyocyte) ND [62]
Rat 2K1C ND (both kidney) (unclipped kidney) ND [61]
Rat 3-week-old
SHR
(caudal ECs) (caudal ECs) (caudal ECs) ND [64]
Rat 12-week-old
SHR
(caudal ECs) (caudal ECs) (caudal ECs) ND [64]
Rat SHR (mesentric ECs) (mesenteric
ECs)
(mesenteric ECs) ND Candesartan increased
expression of Cx37 and Cx40
but decreased expression of
Cx43
[66]
Rat 3-week-old
SHR
(aortic ECs) (aortic ECs) (aortic ECs) ND [65]
Rat 12-week-old
SHR
(aortic ECs &
VSMCs)
(aortic ECs) (aortic VSMCs) ND Normalized endothelial connexin
expression by ACE inhibition.
[65]
Rat L-NAME (aortic ECs) (aortic ECs) (aortic ECs) ND Normalized Cx37 and Cx43
expression by carvedilol
treatment
[63]
Mouse Cx402/2 (RSC) Undetectable (RSC) ND [68]
Rat SHR (renal arteriolar
ECs)
 (renal
arteriolar
ECs)
 (renal arteriolar ECs) ND [67]
Mouse C57BL6 SK1C (aortic VSMCs) (aortic ECs) (aortic VSMCs) (aortic
VSMCs)
Connexin expression partly
normalized by candesartan
[41]
Mouse C57BL6
L-NAME
(aortic VSMCs) (aortic ECs)  (whole aorta lysate) (aortic
VSMCs)
[41]
Mouse Cx402/2 (aortic VSMCs),
(aortic ECs)
Undetectable (aortic VSMCs) (aortic
VMCs)
Connexin expression in VSMCs
reduced by candesartan
[41]
ECs, endothelial cells; ND, not determined; RSC; renin-secreting cells; VSMCs, vascular smooth muscle cells.
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Cx37,Cx43, andCx45 in aortic VSMCs.41 Intriguingly, the expression of
Cx37 in ECs fromCx402/2mice is reduced,10,41,70 possibly pointing to a
common pathway for Cx40 and Cx37 in the transport towards the
plasma membrane. In contrast, the expression of Cx37 and Cx43 in
renin-secreting cells does not seem to be affected byCx40 deficiency.68
7. Role of Cx40 in hypertension
Despite all the above-mentioned data associating hypertension with
changes in connexin expression, evidence that connexins are actually
implicated in hypertensive disease was lacking for a long time and
came only from studies of Cx402/2 mice.12,41,68,69 It appeared that
Cx40 expression in renin-secreting cells in the kidney regulates their se-
cretionof renin (for an excellent review, seeBosco et al.32). Indeed,mice
ubiquitously deficient for Cx40 but also mice with specific deficiency of
Cx40 in renin-secreting cells display increased renin plasma concentra-
tions and are markedly hypertensive.68,71 Moreover, Cx402/2 mice
treated with an AT1 receptor antagonist or with an ACE inhibitor
show reduced blood pressure despite the fact that in these animals
renin plasma levels are even further increased (compared with untreat-
ed Cx402/2 mice).68,71 Interestingly, five somatic mutations in GJA5, the
human gene coding for Cx40, were reported in 2006.72 One of these
mutations, coding for an Ala96Ser substitution, results in the expres-
sion of a protein that localizes efficiently to the junctional plaque but is
unable to form functional channels.72 Surprisingly, the expression of
this Cx40 A96S mutation in C57BL6 mice caused renin-dependent
hypertension characterized by similar blood pressure increases as
observed in Cx402/2 animals.68,71,73 This suggests that actual GJIC
between renin-producing cells may be required for Cx40-mediated
control of renin release. However, a study from Kurtz et al.69 shows
that the mechanism by which Cx40 deficiency leads to increased
renin levels in mice lies in the structural changes that can be observed
in the juxtaglomerular apparatus of Cx402/2 mice and not a reduced
amount of GJIC communication.
GJA5wascloned in199474and itwasthereafter shownthatmutations in
the coding regionof this gene are associatedwith various cardiac arrhyth-
mias. Whether mutations in the coding region of GJA5 such as the Cx40
A96S are associated with hypertension in humans is currently unknown.
Genetic polymorphisms in the human Cx40 gene promoter leading to
reducedCx40expression have, however, beenbe associatedwith hyper-
tension already in 2006.75However, these results could not be confirmed
in a recent study.76 Thus, although the exact molecular mechanism is not
entirely clear and human data regarding the effect of mutations in the
coding region of GJA5 are missing, studies of genetically altered mice
have provided substantial evidence for a role of Cx40 in renin-dependent
hypertension. Of note, several studies have shown that the increased
blood pressure in Cx402/2 mice cannot be fully reversed by treating
the animals with either an AT1 antagonist or an ACE inhibitor.
68,71,77
Thus, additionalCx40-dependentpathwaysmaybe implicated inthe regu-
lation of blood pressure as well. In this regard, the fact that resistance
arteries from Cx402/2 mice display impaired conducted dilatations and
irregular vasomotion, possibly leading to increased peripheral vascular
resistance, is of particular interest.77–79
8. Effect of afterload on the heart
In the beating heart, cardiomyocytes are subjected to a constant cycle
of stretch and contraction. These mechanical forces regulate overall
cell and organ function, both in health and in disease. The coupling
of the contractile machinery of one cell with that of its neighbours
is essential both for effective contraction, and for preservation of
the elastic properties of the cardiac muscle. Molecular complexes
(desmosomes, adherens junctions, and area composita) integrate at
the site of cell contact (the intercalated disc) to provide a cell–cell
mechanical continuum. Also at the intercalated disc, gap junctions
allow for electrical synchrony between cells (Figure 2). When this elec-
trical synchrony is disrupted, as seen in disease states causing a
reduced and heterogeneous expression of Cx43, it predisposes to
electrical re-entry and ultimately to the development of possibly
fatal arrhythmias. While gap junctions and mechanical junctions
were originally described as separate and independent entities,
present data suggest that molecules classically defined as belonging
to one group (e.g. desmosomes) can greatly affect the integrity of
the other (e.g. gap junctions). The mechanisms responsible for this
cross-talk are a subject of intense research in the field.
The response of cardiomyocytes to mechanical load has been exten-
sively studied. Using monolayers of neonatal rat ventricular myocytes
(NRVMs), Zhuang et al.80 showed that unidirectional pulsatile stretch
up-regulates Cx43 expression. This connexin up-regulationwas accom-
paniedbyan increase in conduction velocity. Separate studies showedan
early and transient increase inCx43mRNAincardiomyocytes subjected
to pulsatile stretch.81,82 Thus, the regulation of Cx43 gene expression
could underlie the observed induction of this protein by pulsatile
stretch. However, a reduction of Cx43 protein degradation following
stretch could also be involved. In fact, it seems that stretch is able to
reduce contractile protein turnover inNRVMsunder specific conditions
of stretch degree and orientation.83 Whether a similar effect of stretch
onCx43 protein turnover also takes place remains to be demonstrated.
Several pathways seem to be involved in the regulation of Cx43 expres-
sion by mechanical forces. NRVMs release autocrine–paracrine factors
such as angiotensin II (Ang II), endothelin-1, vascular endothelial growth
factor (VEGF), and transforming growth factor-b (TGF-b).82,84–87Cx43
can be induced by exposure to VEGF or TGF-b and, more importantly,
stretch-dependent induction of Cx43 expression can be abolished by
antibodies directed against VEGF or TGF-b.88 In fact, early stretch-
induced up-regulation of Cx43 seems to be partially mediated by
VEGF, which acts downstream of TGF-b.88 Similarly, Ang II was shown
to induce Cx43 expression in vitro, and stretch-dependent induction of
Cx43 can be prevented by exposure to AT1 receptor antagonists
such as losartan.82 It, thus, appears that several soluble factors that
are released upon pulsatile stretch may promote GJIC between
cardiomyocytes.
In addition to Cx43, short periods of pulsatile stretch were demon-
strated to up-regulatemechanical junction proteins such asN-cadherin,
plakoglobin, and desmoplakin at cell–cell junctions.80,89 Moreover, the
degreeof stretch and themicro-architecture of the cell–cell contact de-
termine the formation of cell–cell adhesions. Indeed, pairs of NRVMs
cultured on deformable substrate show variable expression of mechan-
ical junction proteins depending on their shape (length-to-width ratio)
and the stiffness of the substrate.90 Interestingly, studies of freshly disso-
ciated adult rat ventricularmyocytes that are allowed to reformcell–cell
contact in culture showed that the formation of adherens junctions at
the intercalateddisc is a pre-requisite forCx43gap junction formation.89
In general, gap junction formation is seen as a process that occurs after
mechanical coupling between cells (see also Meyer et al.91). It, thus,
appears that, in vitro, mechanical stretch can also affect Cx43 expression
by modifying the expression and localization of mechanical junction
proteins.
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The overall consensus of in vitro studies is that mechanical stretch
favours Cx43 expression and GJIC in cardiomyocytes. Numerous
studies of animal models and human patients have aimed to investigate
the effect of stretch in vivo. Most studies involved increased left ventricu-
lar afterload, such as encountered with aortic stenosis in human or its
animal model, transverse aortic constriction (TAC), or increased right
ventricular afterload such as pulmonary hypertension. In an initial
study, monocrotaline-induced pulmonary hypertension in rats resulted
in the so-called remodelling of Cx43 expression, defined as a loss of gap
junctions at the centre of intercalated discs and a redistribution of Cx43
to the lateral membrane of cardiomyocytes 4 weeks after induction.92
Interestingly, the remodelling of Cx43 was similar in rats subjected to
TAC for 12 weeks.93 Thus, initial studies examining animals with
severe pulmonary hypertension or TAC-induced left ventricular hyper-
trophy seemed to be in contradiction with in vitro studies. Subsequent
studies that examined animals at different time-points after pressure
overload found a transient increase in Cx43 expression up to 5 days
after TAC, which was followed by a progressive decline in total expres-
sion.94 This biphasic response ofCx43 expression to increasedmechan-
ical stretch corroborates findings in patients suffering aortic stenosis;
Kostin et al.95 showed that in patientswith compensated aortic stenosis,
Cx43 expression is increased compared with healthy subjects and
the protein redistributes to the lateral membrane. However, in patients
suffering fromdecompensated aortic stenosis, the total amount ofCx43
and the number of gap junctions are severely reduced, with a heteroge-
neous pattern of expression within the myocardium. One can thus
postulate that the early increase and redistribution of Cx43 participates
in the compensatory mechanism of the myocardium to overcome
increased afterload. Once the compensatory mechanisms start to fail,
Cx43 expression is reduced and becomes heterogeneous, which in
turn can promote arrhythmias as seen in patients with decompensated
aortic stenosis and, possibly, with pulmonary hypertension.96
The mechanisms leading to Cx43 remodelling are becoming increas-
ingly understood. Dephosphorylation of Cx43 seems to be associated
with the loss and lateralization of Cx43 in monocrotaline-induced
pulmonary hypertension in rats as well as after TAC in mice.94,97 To
determinewhetherCx43phosphorylationwas responsible for gap junc-
tion remodelling, Remo et al.98 generated transgenic knock-in mice
in which phosphomimetic glutamic acids replaced three serines in the
C-terminal domain of Cx43. These serines are known to be phosphory-
latedby casein kinase1d and toplay a role in gap junction assembly. Inter-
estingly, thesemicewere resistant to gap junction remodelling afterTAC
and were less susceptible to the induction of ventricular arrhythmias,
indicating that dephosphorylation of Cx43 is necessary for the remodel-
ling of gap junctions after increased mechanical stretch.
The response to pharmacological blockers of the renin–angiotensin–
aldosterone system also appears to be different between in vitro and
in vivo studies. As mentioned above, Ang II increases Cx43 expression
in vitro, and thiseffect isblockedby losartan. Incontrast, losartanprevented
Cx43 remodelling in rats after TAC,93 and spironolactone prevented or
reversed dephosphorylation and lateralization of Cx43 in mice subjected
to TAC.94 It is thus tempting to speculate that AT1 receptor antagonists
and mineralocorticoid receptor antagonists may have a differential
effect depending on the stage of the disease.
It is now increasingly recognized thatCx43 is part of a largermultimo-
lecular complex involving several typesof intercellular junctionproteins.
Figure2 Ultrastructure of the cardiac intercalated disc. Left: transmission electronmicroscopy image of adultmurine heart showing the close juxtapos-
itionof adesmosome toa gap junction.Right: schematic drawingof potential interactionbetweenplakophilin-2 andCx43at the intercalateddisc.D, desmo-
some; GJ, gap junction; DSG2, desmoglein-2; DSC2, desmocollin-2; PKP2, plakophilin-2; PG, plakoglobin; DP, desmoplakin. Electron microscopy image
reproduced from Delmar and Liang111 with permission from Elsevier.
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In fact, a recent study of adult sheep subjected to pulmonary hyperten-
sion demonstrated that in addition to Cx43, N-cadherin and desmo-
somal proteins (plakoglobin, desmocollin, desmoglein, desmoplakin,
and plakophilin-2)were also remodelled to the lateralmembrane of car-
diomyocytes.99 The lateralization of Cx43 andmechanical junctionswas
associated with the microtubule-associated protein EB1 and the kinesin
proteinKif5b, suggesting that the redistributionof these intercalateddisc
proteins is mediated by microtubule-dependent trafficking.
9. Effect of changes in the
composition of myocardial
mechanical junctions on connexins
Proper electrical andmechanical coupling between cardiomyocytes are
crucial for a normal functionof the heart. Alterations of bothmechanical
junction proteins and gap junction proteins are a prominent feature in
many forms of heart disease such as ischaemia, hypertrophy, and
various cardiomyopathies. There is growing evidence that the different
junctional complexes at the intercalated disc behave in an integrated
manner. Early in vitro studies of gap junction formation showed that pre-
venting adherens junction formation in a tumour cell line through neu-
tralizing antibodies impaired the assembly of gap junctions.91 As the
formation of adherens junctions at the intercalated disc always precedes
Cx43 gap junction formation in cardiomyocytes,89 it seems likely that
any disease process involving adherens junctions would in turn disrupt
Cx43 gap junctions. Similarly, disruption of desmosomes by silencing
one of its components, PKP2, leads to a decrease and an internalization
of Cx43 in NRVMs.100 In addition, pull-down experiments using tagged
proteins showed thatCx43 and PKP2 could precipitatewith each other.
Recently, it was demonstrated that desmocollin-2 could bind to both
Cx43 and plakoglobin, and could thus function as an adaptor protein
between gap junction and desmosome.101 Therefore, it seems that
gap junctions and desmosomes can interact in several ways, supporting
the concept of a macromolecular complex of electrical and mechanical
junctional proteins.
Several animal models have been used to investigate the conse-
quencesof alteredmechanical junctionson connexins. First, a condition-
al heart-specific deletion of N-cadherin was shown to disrupt the
intercalated disc, with the loss of adherens junctions and desmosomes.
In thismodel,Cx43 (andCx40 in the atria)was rapidlydown-regulated in
themyocardium after the loss ofN-cadherin, whichwas associatedwith
a reduction in ventricular conduction velocity.102,103 A whole class of
proteins provides a mechanical link between the adherens junction or
the desmosome and the cytoskeleton (actin filaments or intermediate
filaments, respectively). Interestingly, alterations in these proteins also
affect Cx43. For instance, deletion of the gene coding for aT-catenin,
which bindsb-catenin to actin,was shown to reduceCx43 and PKP2ex-
pression in cardiomyocytes.104 b-Catenin and plakoglobin, two other
adaptor proteins, also affect Cx43. They both connect the adherens
junction to actin filaments and seem to be able to substitute for each
other. In addition, plakoglobin also binds to desmosomal cadherins. In
that sense,mice deficient forb-catenin have amuchmilder cardiomyop-
athy than animals lacking plakoglobin, and mice deficient for both
adaptor proteins suffer frommuchmore severedisease. The expression
of Cx43 seemed to parallel the severity of the phenotype, with a step-
wise decrease in Cx43 from the control, to b-catenin-deficient, to
plakoglobin-deficient, and finally to the double knock-out animals.105
Interestingly, this down-regulation of Cx43 preceded the onset of
inducible arrhythmias, suggesting that additional mechanisms are neces-
sary for the occurrence of arrhythmias.
Thus, in vitro, and in animal models, an intact mechanical junction
between cardiomyocytes is necessary for a proper Cx43 expression
and localization. The down-regulation of Cx43 caused by alterations in
the mechanical junctions seems to be an early event in the progression
of disease, and it predates overt arrhythmogenic events in animals. In
humans, arrhythmogenic right ventricular cardiomyopathy (ARVC,
also sometimes referred to as ARVD or AC) is considered a desmo-
somal disorder. Indeed, more than half of patients have a known muta-
tion in one of the five genes coding for desmosomal proteins.
Interestingly, a recent study investigating the expression of various junc-
tional proteins in patients suffering fromARVC showed that both plako-
globin andCx43weredown-regulated in all regionsof theheart fromthe
majority ofARVCpatients, regardless of the underlying genetic disorder
(11 out of 11 patients in Asimaki et al.106 and 14 out of 20 patients in
Noorman et al.107). Other desmosomal proteins, such as desmoplakin
and PKP2, were more variably expressed between patients. It, thus,
appears that remodelling of Cx43 is a consistent feature in patients
with ARVC, which could participate in the arrhythmogenic substrate
of the disease. In fact, it is well known that remodelling of Cx43
occurs early in the progression of the disease, before overt structural
damages.89,108,109 This is in contrast with other cardiac pathologies,
such as ischaemic disease, hypertrophic cardiomyopathy, or dilated
cardiomyopathy, where remodelling of Cx43 appears at later stages
after considerable structural alterations.
Recent studies demonstrate that in addition to Cx43, the major
a-subunit of the cardiac sodium channel, Nav1.5, is also remodelled in
patients suffering from ARVC.107 In vitro studies showed that Nav1.5 is
associatedwithPKP2and that knockdownofPKP2affects theproperties
of the sodium channel and reduces conduction velocity in cultured
cardiomyocytes.110 Thus, in addition to inducing Cx43 remodelling,
alterations in mechanical junction proteins could also affect the
cardiac sodium current. This would constitute an additional mechanism
underlying arrhythmias in ARVC.
In conclusion, physiologicalCx43expression in themyocardium is de-
pendent on the proper expression and localization of mechanical junc-
tion proteins at the intercalated disc. Cx43 is consistently affected in
arrhythmogenic diseases caused by mutations in mechanical junction
proteins.
10. Summary
It has beenwell established that endothelial gap junctions are sensitive to
shear stress, which changes their relative connexin composition. While
Cx37 is up-regulated by HLSS and Cx43 by OSS, arterial Cx40 seems
relatively insensitive to shear stress. These differences in connexin ex-
pression create endothelial communication compartments that may
play a role in disease development, i.e. that may determine location of
atherosclerotic lesions, but that may also participate in physiological
processes such as valve formation. The effect of mechanical stretch as
imposed by increased afterload on the heart is fairly established as
well. Stretch seems to first induce a compensatory increase of Cx43
in cardiomyocytes, which is followed by a reduction and remodelling
of Cx43 and associated mechanical junction proteins. Whether there
is reciprocal regulation between mechanical and gap junctions in ECs
and VSMCs is unclear at this moment. Moreover, with regard to hyper-
tension, the effects on connexins seem to depend very much on the
model studied, and data remain inconsistent even when the same
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model was used. Importantly, connexin expression is normalized by
pharmacologically blocking the renin–angiotensin system in several
models of systemic hypertension, making this an exciting new target
for future drug development.
There is growing interest in the study of the inter-relation between
mechanical forces, mechanical junctions, and connexin expression in
the cardiovascular system. In the heart, the idea that the loss of Cx43
from the intercalated discmay increase the susceptibility to arrhythmias
is quite straightforward. However, the consequences of an increase in
Cx43 expression, as seen in the early stages after increased afterload,
are less obvious.One can hypothesize that in addition to increased elec-
trical coupling, the induction of Cx43 expression could also favour the
transfer of larger molecules such as metabolites, siRNA,2 or miRNA3
between cardiomyocytes that are subjected to increased strain. This
could lead to the homogeneousmyocyte hypertrophy seen in compen-
sated aortic stenosis. Interestingly, Cx43 is also up-regulated in VSMCs
of arteries subjected to hypertension. One could imagine a similar com-
pensatory mechanism in response to increased stretch, leading to
increased resistanceof the arteries tobloodpressure.Regulationof con-
nexins by shear stress seems to be a consistent feature, independently of
the vascular bed. Whereas a function for Cx37 induction has been
demonstrated in lymphatic valve development, the consequences of
shear stress-dependent connexin regulation in blood vessels or in
other regions of lymphatic vessels are only hypothetical so far. The
main limitation resides in identifying the nature of themolecules diffusing
through endothelial gap junctions. It is thought provoking that Cx43 and
Cx37, which form gap junction channels with very different permeabil-
ities, are inversely regulated by shear stress in ECs. It suggests that shear
stress patterns, by modulating the ratio of Cx37 and Cx43, tightly
regulate the permeability of endothelial gap junctions to distinct
molecules. The precise identification of such molecules would greatly
advance the understanding of the role of the synchronization induced
by mechanotransduction.
Finally, long-standing questions remain as to the nature of the mes-
sages, the relevance of connexin diversity, and their importance on
disease initiation or progression. Connexins have been seen as exciting
pharmacological targets for years and yet, they have been hidden from
the touch of selective drugs. Although the contribution of connexins
to the maintenance of normal cellular functions is now relatively well
understood, the specific contribution of connexins to disease is less
clear. Whether it is in the blood vessels or in the heart, there is
growing evidence that cross-talk of connexins with molecules involved
in mechanical events is not coincidental or irrelevant, but rather the
resultof the fact that thesemolecules all livewithinmolecularcomplexes
where connexins are not only makers of gap junctions or, say,
plakophilin-2 a maker of desmosomes. They are all part of a
protein-interacting network that at the end regulates adhesion, cell–
cell coupling, and excitability in the cardiovascular system.
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